Case Study: Diagnostic Device Distributor Achieves NABP OTC Medical Device Accreditation to Secure Pharmacy Chain Contract
Situation Overview
A regional distributor of continuous glucose monitoring (CGM) systems and related diagnostic supplies had been supplying independent pharmacies and small regional pharmacy chains for several years. When the company submitted a proposal to supply a major national pharmacy chain under a diabetes care supply program, the chain's supplier qualification team required NABP OTC Medical Device Distributor Accreditation as a condition of consideration. The distributor had strong operations and a clean regulatory history but had never pursued formal accreditation. The national pharmacy chain gave the distributor 90 days to initiate the accreditation process and provide evidence of eligibility letter receipt. The company engaged IHS immediately.
Challenges
- Supply chain documentation gaps: The distributor purchased CGM systems from a mix of manufacturer direct and authorized secondary distributors. While the supply chain was clean, the distributor did not have a formal supplier qualification program or documented supply chain provenance records for each product lot. NABP's requirement for manufacturer-traced supply chain documentation was the most significant gap.
- No formal recall procedure: The distributor had never executed a recall and had no documented recall procedure. When a CGM manufacturer issued a field safety corrective action in a prior year, the distributor had handled it informally. NABP's accreditation criteria require documented, tested recall procedures.
- Liability insurance documentation: The distributor's liability insurance was current and adequate, but the policy documentation was not organized in the format required for the NABP application. The distributor also lacked a documented process for confirming insurance coverage adequacy against any new product categories added to the distribution portfolio.
- Compressed timeline: The 90-day window for demonstrating Supply Chain Inspection initiation to the pharmacy chain was tight, particularly given that the Supply Chain Inspection must be scheduled with NABP and completed before the full application can be submitted. IHS needed to prepare the distributor for the inspection as rapidly as possible.
IHS Approach
Thomas G. Goddard, JD, PhD — IHS's principal consultant and former Chief Operating Officer and General Counsel of URAC — conducted an initial eligibility assessment confirming the distributor's OTC Medical Device Distributor Accreditation eligibility and identifying the four primary gaps. The engagement was structured for maximum speed given the 90-day milestone.
Supplier Qualification Program Development
IHS developed a formal supplier qualification program covering verification procedures for manufacturer direct and authorized secondary distributor suppliers. The program included a supplier authorization verification checklist, an FDA registration check protocol, a product lot provenance documentation template, and a quarterly supplier status review process. Provenance documentation was retroactively completed for the distributor's active product inventory using existing purchase records and manufacturer authorization confirmations, providing historical documentation from the date of the program's go-live.
Recall Procedure Development
IHS developed a comprehensive recall and field safety corrective action procedure covering FDA recall classification definitions, distributor notification and quarantine responsibilities, downstream customer notification requirements, product retrieval documentation, and regulatory report filing. A tabletop recall exercise was conducted with the operations manager and two warehouse supervisors, generating documentation of recall readiness. The exercise also identified one improvement: the customer notification list was maintained in an email contact database that was not synchronized with the current customer list in the order management system. The discrepancy was corrected before the Supply Chain Inspection.
Insurance Documentation Organization
IHS worked with the distributor's insurance broker to compile the required insurance documentation in the format needed for the NABP application — current certificate of liability insurance, policy summary, and confirmation of coverage adequate for the device categories distributed. A documented annual insurance review process was established to ensure adequacy is verified when new product categories are added.
Supply Chain Inspection Preparation and Execution
IHS conducted a full mock Supply Chain Inspection walkthrough covering all major inspection areas — facility layout and security, temperature monitoring (not applicable for the CGM products distributed by this client but documented as such), documentation systems access, supplier qualification records, and recall procedure review. One minor gap was identified: a fire extinguisher inspection log that had lapsed. Corrected immediately. The actual NABP Supply Chain Inspection was completed in week 7 of the engagement. The eligibility letter was received in week 9 — within the pharmacy chain's 90-day window.
Accreditation Application and Grant
IHS submitted the full accreditation application following receipt of the eligibility letter. NABP granted OTC Medical Device Distributor Accreditation in week 16 of the engagement — approximately four months after initial engagement start.
Outcomes
- NABP Supply Chain Inspection eligibility letter received in week 9 — within the pharmacy chain's 90-day milestone requirement
- NABP OTC Medical Device Distributor Accreditation granted in week 16
- National pharmacy chain supplier qualification approved; contract executed within 30 days of accreditation grant
- Formal supplier qualification program established with provenance documentation for all active inventory
- Comprehensive recall procedure developed and tabletop-tested
- Zero Supply Chain Inspection findings (one pre-inspection gap corrected before inspection)
- Insurance documentation organized and annual review process established
Key Lessons
Supply chain provenance documentation is not the same as supply chain cleanliness. This distributor had a clean supply chain — all product came from legitimate sources. The gap was documentation, not practice. NABP does not evaluate whether your supply chain is clean based on your word; it evaluates whether you can prove it with documentation tracing each product lot to the manufacturer. Building the documentation infrastructure retroactively is possible but takes time. Building it proactively — before an accreditation requirement appears — is always preferable.
Recall procedures require customer list synchronization. The tabletop exercise in this case found a customer notification list that was out of sync with the actual customer database. This is a common gap in distribution operations that maintain customer contact information across multiple systems. A recall notification to an outdated email list is a recall notification that does not reach the customers who need it. Every distributor should periodically reconcile its recall notification list against its active customer records.
Trading partner requirements drive accreditation demand. This distributor did not pursue accreditation until a major national pharmacy chain required it. As pharmacy chains and health plans tighten their supplier qualification requirements, accreditation is becoming a prerequisite for large-volume distribution contracts, not an optional differentiator. Distributors who pursue accreditation proactively are in a stronger position when the requirement appears than those who are scrambling to comply on a deadline.
Does Your Device Distribution Operation Need NABP Accreditation?
IHS helps OTC medical device distributors navigate eligibility, the Supply Chain Inspection, and the full NABP accreditation process efficiently. Schedule a Free Discovery Session with Thomas G. Goddard, JD, PhD — former Chief Operating Officer and General Counsel of URAC.